Skip to content

To study the effects of yoga in cervix cancer patients undergoing treatment

Effect of Yoga on patients undergoing chemoradiation in carcinoma Cervix- A randomized controlled study

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/014331
Enrollment
200
Registered
2018-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnosed cases of Cervical cancer

Interventions

Intervention1: Yoga therapy: Yoga sessions were conducted for one hour daily which included a set of breathing practices, postures with awareness ( asanas), meditation and yogic relaxations. Control

Sponsors

Ministry of Ayush Government of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women with Stage 1B â?? IIIB cervical cancer, who are undergoing concurrent chemoradiation. 2. The participants will need to be 18 years of age or older. 3. Participants must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 4. Newly diagnosed with a histologically or cytologically confirmed ca Cervix 5. Ability to understand and the willingness to sign an institutional review board (IRB)-approved written informed consent document 6. No contraindications to participating in a yoga program 7. Able to come for clinic visits, and attend weekly classes, and fill out 8. Gives informed consent, agrees to be randomly assigned

Exclusion criteria

Exclusion criteria: 1. Patients who have practiced yoga or taken yoga classes in the year prior to diagnosis will be excluded. 2. Participants who have regularly (defined as 4 or more days per week) engaged in vigorous physical activity (i.e., causes heavy breathing, sweating, rapid fatigue; can be sustained for short periods, like running or swimming strongly) over the past 4 weeks 3. Patients with extreme mobility issues (e.g., unable to get in and out of a chair unassisted) will be excluded. 4. Eastern Cooperative Oncology Group (ECOG) performance status of >2 5. Any concurrent medical condition that was likely to interfere with the treatment, 6. Major psychiatric, neurological illness or autoimmune disorders, and 7. known metastases

Design outcomes

Primary

MeasureTime frame
a) To evaluate the effect of Yoga on Quality of life (QOL), Well Being, Fatigue and Depression, Distress and anxiety b) To evaluate the effect of yoga on acute effect of chemoradiation (like nausea, vomiting and diarrhoea, Bowel, Bladder effects and skin changes). Timepoint: 0, mid therapy, completion, monthly interval for 3 months

Secondary

MeasureTime frame
To evaluate effect of yoga on mood, sleep and thyroid functionsTimepoint: 0, mid therapy.completion, monthly interval for 3 months

Countries

India

Contacts

Public ContactDr Govardhan H B

Kidwai Memorial institute of Oncology

govardhanhb@gmail.com09971058822

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026